Trials / Completed
CompletedNCT03728309
JUVÉDERM® VOLITE™ XC for Cheek Skin Smoothness
Protocol Title: A Randomized, Multicenter, Evaluator-blind, Controlled Study to Evaluate the Safety and Effectiveness of JUVÉDERM VOLITE™ XC Injectable Gel for the Improvement in Cheek Skin Smoothness
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 209 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This is a pivotal study to collect safety and effectiveness data on JUVÉDERM VOLITE™ XC for improvement in skin smoothness of the cheeks in order to support FDA product approval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JUVÉDERM VOLITE™ XC | Intradermal, needle in multiple microdepot injections across both cheeks. |
Timeline
- Start date
- 2018-11-09
- Primary completion
- 2020-07-17
- Completion
- 2020-07-17
- First posted
- 2018-11-02
- Last updated
- 2022-12-19
- Results posted
- 2022-12-19
Locations
14 sites across 2 countries: United States, Puerto Rico
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03728309. Inclusion in this directory is not an endorsement.